Searched for
PHARMACEUTICAL MERGERS
SBI in $1 billion funding for Sun Pharma’s US dealState Bank of India is set to commit up to $1 billion to fund Sun Pharmaceutical Industries Ltd.'s $12 billion acquisition of Organon & Co....- Quant Mutual Fund bets on under-owned, under-researched, undervalued and neglected territory stocks for alpha generationQuant Mutual Fund is strategically focusing on under-owned, under-researched, and neglected market segments for higher alpha generation. Th...
- HAB Pharma merges Signature Phytochemicals, eyes Rs3,000 crore revenue by 2030HAB Pharma and Signature Phytochemicals have merged, creating a consolidated entity with a turnover of Rs600 crore. This strategic move aim...
- Sun Pharma explores funding mix for $12 billion Organon dealGlobal lenders are exploring various financing options for Sun Pharmaceutical Industries' proposed $12 billion acquisition of Organon & Co....
- Sun Pharma-Organon deal: How a $12-billion merger will reshape India's pharma landscapeSun Pharma is set to nearly double its revenue to $12 billion with the acquisition of Organon, creating a global pharmaceutical giant. The ...
- Sun Pharma to acquire Organon for $11.75 billion in India’s biggest pharma dealSun Pharma, led by Dilip Shanghvi, has agreed to acquire US-based Organon in an all-cash deal worth $11.75 billion, marking the largest acq...
- Sun Pharma shares jump over 9% after firm announces $12 billion Organon acquisitionSun Pharmaceutical Industries' shares surged after announcing the $11.75 billion acquisition of US-based Organon & Co., a global leader in ...
- Sun Pharma to buy Organon in $11.75 billion all-cash dealSun Pharmaceutical Industries has agreed to acquire U.S. drugmaker Organon & Co in an all-cash deal valued at approximately $11.75 billion,...
- AI chipmaker Forge Nano to list via $1.6 billion SPAC dealForge Nano, a US-based semiconductor equipment and advanced materials company, plans to go public through a $1.6 billion blank-check deal w...
- Bain Capital sole contender for Vitabiotics buyBain Capital has emerged as the frontrunner to acquire Vitabiotics, as rival bidders TPG Capital and EQT exit the process, potentially lowe...
- With sights on huge gains, Biocon to scale up AI focusBiopharma major Biocon is significantly scaling up its adoption of artificial intelligence across its operations, from R&D to manufacturing...
- Suven, Cohance aim to double combined business revenue to Rs 6,000 cr by FY29Suven Pharmaceuticals and Cohance Lifesciences plan to merge and aim to double their revenue to Rs 6,000 crore by FY29 through organic and ...
- DRL, Cipla, Aurobindo among others to buy products from TevaThe remedy requires Teva to divest the drug portfolio to 11 firms and marks the largest drug divestiture order in an FTC pharmaceutical mer...
- Sun Pharma to delist Ranbaxy post $4-bn merger; swap ratio set at 8:10Sun Pharma in a filing to BSE said that Ranbaxy shareholders will get 8 shares of Sun Pharma for every 10 stocks they hold. Both stocks end...
- Shares of Sun Pharma, Ranbaxy rise after regulatory nods for merger dealAt end of trade, Sun Pharmaceutical Industries ended at Rs 1,039.85, up 1.55 per cent and Ranbaxy Laboratories closed at Rs 819.55 apiece, ...
- Strides Arcolab shares gain 9% on merger with Shasun PharmaShares of Strides Arcolab gained over 9 per cent today after the company and Shasun Pharmaceuticals announced their merger .
- Glenmark Pharma gets BSE nod to merge subsidiaries with itselfThe approval is valid for six months, during which the company will apply to the High Court for further clearance of the proposal.
- Cadila Health, Torrent Pharma mulling merger: SourcesIf talks succeed, the new entity will become India's third largest pharma co in terms of sales going forward after Sun Pharmaceuticals & Dr...
- Pharmaceutical companies should consider mergers: Dilip ShanghviPharmaceutical companies, who are battling growing competition from each other and resurgent multinationals, may have to shake hands.
- Sun gets notice for from Taro for termination of merger pactDomestic drug firm Sun Pharmaceutical, which had acquired Israel-based Taro Pharma for 455 million dollar last year, today said the Israel-...
Load More
